Distinguishing the progression of an endometrioma: Benign or malignant?

BAŞTU, Ercan; Onder, SEMEN; Demiral, Irem; Ozsurmeli, Mehmet; Keskin, Gulsah; TAKMAZ, Özgüç; Ozaltin, Selin; GÖRGEN, Hüsnü; GÜNGÖR, Mete; Yavuz, Ekrem; Buyru, Ercan

doi:10.1016/j.ejogrb.2018.09.026

Distinguishing the progression of an endometrioma: Benign or malignant?

BAŞTU E., Onder S., Demiral I., Ozsurmeli M., Keskin G., TAKMAZ Ö., ...Daha Fazla

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, cilt.230, ss.79-84, 2018 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 230
Basım Tarihi: 2018
Doi Numarası: 10.1016/j.ejogrb.2018.09.026
Dergi Adı: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.79-84
İstanbul Üniversitesi Adresli: Evet

Özet

Objective: To elucidate the immunohistochemical (IHC) differences of endometrioma tissues that may have the potential to progress to ovarian clear cell carcinoma (OCCC) by using KRAS, HNF1 beta, PIK3CA, PPP2R1A, and ARID1A as biomarkers.